- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
While the spot price has trended higher for the last year, Cameco warns that could be reversed if new projects come online or other projects are ramped up.
Despite the spot price of uranium steadily increasing in 2018, Canada’s largest uranium producer Cameco (TSX:CCO,NYSE:CCJ) is still cautiously optimistic about the future of new projects.
Depressed uranium prices in 2017 and the early part of 2018 forced Cameco to place the McArthur River mine — the country’s largest uranium mine — on care and maintenance indefinitely, removing a significant supply from the market, which helped the spot price rally in the latter half of the year.
“Spot prices have increased by more than 20 percent since the beginning of 2018, and some interest in long-term contracting is emerging,” noted the company’s recently released discussion and analysis report.
“However, uranium prices and contracting opportunities are still not where they need to be to restart the significant idled production capacity that exists, and are far below the level that would warrant investment in value-adding growth opportunities.”
The extended closure of McArthur, which was announced in late-July 2018, removed 18 million pounds of uranium from the market. Prior to the announcement, the spot price of uranium sat at US$22.65, five days after Cameco revealed its plans to extend the McArthur closure the spot price climbed to US$25.78.
Today (February 11), the U3O8 spot price sits at US$28.90.
“We saw a significant improvement in the spot market driven by substantial production cuts, cuts to some secondary supplies, a reduction in producer inventories, and an increase in demand for uranium in the spot market from producers and financial players,” Tim Gitzel, Cameco’s president and CEO noted in the Q4 press release.
“However, the term market remains tentative driven largely by market access and trade policy issues.”
Concern over spot price movement wasn’t the only issue Cameco was confronted with in 2018. After battling with the Canada Revenue Agency over the 2003, 2005 and 2006 tax years, the Tax Court of Canada ruled in Cameco’s favor.
The win not only vindicated the uranium company, it raised Cameco’s shares 15 percent.
“Despite these improvements in the uranium market, we believe there is still a need for some caution in the near term,” noted the company announcement. “It is important to remember that much of the supply that has been removed from the market is a result of supply curtailment not supply destruction.”
While the spot price has trended higher for the last year, Cameco warns that could be reversed if a bunch of new projects come online or other projects are ramped up.
The report stated: “There is plenty of idle tier-one production and tier-one expansion capabilities, as well as idle tier-two production and expansion capabilities. And, we can’t lose sight of material sitting with financial players. This is capacity that can come back to the market relatively quickly.”
A widespread restart could have negative implications to a delicate market that is still in the midst of a recovery.
“As a result, new supply poses a significant risk to the uranium market recovery,” Cameco’s report highlights. “Today, we believe even the promise of new supply could create a headwind and put downward pressure on uranium prices.”
Concern over the US implementing domestic uranium production quotas, or levying heavy tariffs on foreign uranium is also weighing on the sector and could potential create supply problems down the road.
Cameco shares were up 2.40 percent on Monday (February 11), trading at C$16.88.
Don’t forget to follow us @INN_Resource for real-time updates!
Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.